Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP326301.RARZUuXQYCnw9_NcO-4wtpSNhNorO-kegdSGoT1o6k0rM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP326301.RARZUuXQYCnw9_NcO-4wtpSNhNorO-kegdSGoT1o6k0rM130_assertion type Assertion NP326301.RARZUuXQYCnw9_NcO-4wtpSNhNorO-kegdSGoT1o6k0rM130_head.
- NP326301.RARZUuXQYCnw9_NcO-4wtpSNhNorO-kegdSGoT1o6k0rM130_assertion description "[Furthermore, several central and peripheral nervous system tumors express CRF receptors: medulloblastomas, paragangliomas, neuroblastomas, and some meningiomas express CRF(1) receptors, but ependymomas or Ewing sarcomas do not.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP326301.RARZUuXQYCnw9_NcO-4wtpSNhNorO-kegdSGoT1o6k0rM130_provenance.
- NP326301.RARZUuXQYCnw9_NcO-4wtpSNhNorO-kegdSGoT1o6k0rM130_assertion evidence source_evidence_literature NP326301.RARZUuXQYCnw9_NcO-4wtpSNhNorO-kegdSGoT1o6k0rM130_provenance.
- NP326301.RARZUuXQYCnw9_NcO-4wtpSNhNorO-kegdSGoT1o6k0rM130_assertion SIO_000772 12843181 NP326301.RARZUuXQYCnw9_NcO-4wtpSNhNorO-kegdSGoT1o6k0rM130_provenance.
- NP326301.RARZUuXQYCnw9_NcO-4wtpSNhNorO-kegdSGoT1o6k0rM130_assertion wasDerivedFrom befree-20150227 NP326301.RARZUuXQYCnw9_NcO-4wtpSNhNorO-kegdSGoT1o6k0rM130_provenance.
- NP326301.RARZUuXQYCnw9_NcO-4wtpSNhNorO-kegdSGoT1o6k0rM130_assertion wasGeneratedBy ECO_0000203 NP326301.RARZUuXQYCnw9_NcO-4wtpSNhNorO-kegdSGoT1o6k0rM130_provenance.